Table 3.

Clinical events in the past 4 years in bmMSC-treated patients included in the long-term follow-up. Number of adverse events in total, [in number of patients].

	Cohort 1 [n = 4]	Cohort 2 [n = 4]	Cohort 3 [n = 5]
Perianal abscess	2 [1]		4 [3]
Activity CDa	1 [1]	1 [1]	1 [1]
Infectionb	4 [2]	1 [1]	2 [2]
Gout	1 [1]
Psoriasis guttae	1 [1]
Uveitis		2 [1]
Malignancyc		1 [1]

CD, Crohn’s disease.

^aIncluding diversion proctitis.

^bPneumonia, otitis media, fungal infection, periodontal abscess, laryngitis.

^cB-cell lymphoproliferative disease.